Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report
=====================================================================================================================================================================================================================================================

* Carolin Blumendeller
* Julius Boehme
* Maximilian Frick
* Martin Schulze
* Antje Rinckleb
* Christina Kyzirakos
* Simone Kayser
* Maria Kopp
* Sabine Kelkenberg
* Natalia Pieper
* Oliver Bartsch
* Dirk Hadaschick
* Florian Battke
* Arnulf Stenzl
* Saskia Biskup